(PharmaNewsWire.Com, September 03, 2019 ) Market Overview • IVF is a type of assisted reproductive technology used for infertility treatment and gestational surrogacy. A fertilized egg may be implanted into a surrogate's uterus, and the resulting child is genetically unrelated to the surrogate. IVF is generally not used until less expensive and invasive options have failed or been determined unlikely to work. High success rates, live birth rates, rise in infertile population are some of the drivers of the market. • The IVF Devices and Consumables Market size was worth $ XX billion in 2018 and is forecasted to reach $ XX billion by 2026, at a CAGR of XX% during the forecast period.
Market Dynamics • IVF Devices and Consumables Market is driven by increase in global infertility rates, increased number of sexually transmitted diseases, technological advancement associated with IVF devices, increase in donation of gametes. • Increase in global infertility rates is one of the dominating factors propelling the market. According to WHO, in 2010, 48.5 million couples worldwide are unable to have a child. They found that 1.9 percent of women aged 20-44 who wanted a child were unable to have their first live birth and 10.5 percent of women who had previously given birth were unable to have another baby after five years of trying. • Increased number of sexually transmitted diseases is expected to boost the market. Sexually transmitted infections (STIs) like Chlamydia and gonorrhea are the leading preventable cause of infertility by causing 70% of pelvic inflammatory diseases (PID) responsible for tubal damage. Chlamydia can also cause fallopian tube infection without any symptoms. PID may also cause permanent damage to the fallopian tubes, uterus, and surrounding tissues, which can lead to infertility. CDC has estimated that around 2.86 million cases of Chlamydia and 820,000 cases of gonorrhea occur annually in the US. WHO reported that in 2019, more than 1 million sexually transmitted infections (STIs) are acquired every day. • However, high costs associated with IVF procedures, complications related to IVF treatment, and low awareness of IVF services are hampering the market growth. In 2011, direct costs per couple ranged from approximately $13,000 in the US to over $4,000 in the UK, Australia, Germany and $112,799 in California.
Market Segmentation • On the basis of products, the IVF Devices and Consumables Market is segmented into Instruments, Reagent & media and Accessory and disposables. The instrument segment is further divided into sperm separation system cryosystem, imaging system incubator, IVF cabinet, micromanipulator, and others. Reagent & media is sub segmented into semen processing media, cryopreservation media, embryo culture media, ovum processing media.
• The ability to freeze and thaw embryos successfully is one of the significant advancement in assisted reproductive technology (ART). New trends in assisted reproduction technology (ART) include Preimplantation genetic screening (PGS), Preimplantation Genetic Diagnosis (PGD), Egg Vitrification, Time Lapse Embryoscope, Endometrial Receptivity Array (ERA).
• On the basis of technology, the IVF Devices and Consumables Market is segmented into frozen embryo IVF, fresh Embryo IVF, donor egg IVF.
• On the basis of end-users, the IVF Devices and Consumables Market is segmented into hospitals, surgical centers and others. The surgical centers are expected to boost the market. This is owing to the fact that these centers are providing facilities for surgical sperm retrieval and fertility enhancing surgeries such as tubal surgery, adhesiolysis, tubal reversal surgery, and various other techniques that can lead to conception.
Geographical Analysis • North America is dominating the IVF Devices and Consumables Market in 2018 and estimated to hold largest market size over the forecast period (2019-2026). This is owing to higher live birth rates using ART, favorable reimbursement schemes, rising prevalence of sexually transmitted diseases like Chlamydia and gonorrhea in the region. • For instance, based on CDC’s 2017 Fertility Clinic Success Rates Report, there were 284,385 ART cycles performed at 448 reporting clinics in the US during 2017, resulting in 68,908 live births and 78,052 live born infants. Of the 284,385 ART cycles performed in 2017, 87,535 were egg or embryo banking cycles where it was intended to freeze all resulting eggs or embryos for future ART cycles and for which we would not expect a resulting pregnancy or birth. Approximately 1.7% of all infants born in the US, every year are conceived using ART. • However, over the forecast period (2019-2026), the Asia-Pacific is expected to dominate the IVF Devices and Consumables Market. The Asia Pacific Initiative on Reproduction (ASPIRE) consists of a task force of clinicians and scientists who are involved in monitoring and managing fertility and Assisted Reproductive Technology (ART). Such initiatives are promoting awareness among consumers which is driving the growth of the global IVF and consumables market.
Competitive Landscape Some of the major players in the IVF Devices and Consumables Market are • Cook Medical Inc., IVF Store, • Fujifilm Holdings Corporation, • Merck KGaA, • Others
About Us DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information: Sai Kiran Sales Manager at Data M Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
